Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Corcept Therapeutics Incorporated CORT has been having a fabulous 2024, with its share price increasing 60.5% year to date as of Nov. 5, 2024.This company engages in the discovery and development of drugs...

CORT : 51.40 (+0.49%)
COLL : 29.70 (-2.43%)
IONS : 35.63 (+0.11%)
Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Pharmaceuticals: Q3 Earnings Snapshot

IONS : 35.63 (+0.11%)
New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

IONS : 35.63 (+0.11%)
BIIB : 146.47 (-0.62%)
IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag

Ionis Pharmaceuticals, Inc. IONS announced that the FDA has granted a Fast Track designation to its investigational RNA-targeted therapy zilganersen for treating Alexander disease (AxD), an ultra-rare...

KRYS : 164.83 (+2.49%)
FULC : 4.35 (+7.94%)
IONS : 35.63 (+0.11%)
ANIP : 53.35 (-1.68%)
Ionis Pharmaceuticals: Q2 Earnings Snapshot

Ionis Pharmaceuticals: Q2 Earnings Snapshot

IONS : 35.63 (+0.11%)
Ionis Pharmaceuticals: Q1 Earnings Snapshot

Ionis Pharmaceuticals: Q1 Earnings Snapshot

IONS : 35.63 (+0.11%)
Ionis Pharmaceuticals: Q4 Earnings Snapshot

Ionis Pharmaceuticals: Q4 Earnings Snapshot

IONS : 35.63 (+0.11%)
Markets Today: Stock Index Futures Add to Record Highs on U.S. Economic Optimism

Morning Markets March E-Mini S&P 500 futures (ESH24 ) are up +0.35%, and March Nasdaq 100 E-Mini futures (NQH24 ) are up +0.57%, both at new all-time nearest-futures highs. Stock index futures this morning...

ESH25 : 6,001.75s (+1.14%)
NQH25 : 21,566.50s (+0.88%)
SMCI : 31.59 (+1.12%)
ZS : 187.38 (+2.28%)
M : 16.24 (+2.46%)
S : 22.43 (+0.45%)
IONS : 35.63 (+0.11%)
NS : 21.96 (-1.83%)
NET : 112.69 (+3.79%)
ADM : 50.49 (+2.25%)
BA : 177.35 (+0.18%)
RILY : 4.98 (-2.16%)
Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Pharmaceuticals: Q3 Earnings Snapshot

IONS : 35.63 (+0.11%)
Ionis to hold third quarter 2023 financial results webcast

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, November 2nd at 11:30 a.m. Eastern...

IONS : 35.63 (+0.11%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar